Paul de Potocki, MSc, is Chief Business Officer at RSPR Pharma AB. He has more than 20 years’ experience working in the life sciences industry. Paul has served as VP Global Sales & Marketing at Pharmacia & Upjohn, SVP Strategic Marketing at Fresenius Kabi and SVP Commercial Operations at Biovitrum AB, now SOBI AB. He has also served as CEO of asthma device company Aerocrine AB. He has executed several significant international licensing, co-development and M&A transactions. He currently serves as chairman of the board of Klaria Pharma Holding AB. Paul gained his MSc from the Royal Institute of Technology in Stockholm.
Asthma